NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year

Latest results from FREEDOM study show continued, significant relief of depressive symptoms, which have been implicated in higher rates of hospitalization and death among ESRD patients LAWRENCE, Mass., March 9 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufa...

High-flux hemodialysis prolongs survival in many patients with CKD

High-flux hemodialysis (which removes large toxins) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN). The results suggest that this procedure cou...

First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary

LAWRENCE, Mass., Jan. 6 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their five-year anniversary of home hemodialysis treatment with the NxStage(R) Syste...

NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy

Patient adoption of daily home therapy continues to grow; Positive data supports broader acceptance within ESRD community. LAWRENCE, Mass., Nov. 3 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced that 3,...

Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award

MOUNTAIN VIEW, Calif., Aug. 28 /PRNewswire/ -- The 2008 European Hemodialysis Emerging Company of the Year Award is presented to Redsense Medical in recognition of its pioneering Redsense -- a unique blood loss detecting device. "Redsense detects the loss of blood during hemodialysis and may s...

Renal Solutions, Inc. Announces FDA 510(k) Clearance of New Design of the Allient(R) Sorbent Hemodialysis System for Chronic and Acute Hemodialysis

WARRENDALE, Pa., Oct. 22 /PRNewswire/ -- Renal Solutions, Inc., the exclusive provider of advanced sorbent hemodialysis products and services for treatment of patients with renal failure, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...

Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients

For patients on hemodialysis, the use of dialysis filters coated with vitamin E may provide a simple new approach to the common problem of anemia, reports a paper presented at the American Society // of Nephrology's 39th Annual Meeting and Scientific Exposition in San Diego. Dr. Dinna Cruz and...

Nephrologists Indicate High Interest in AMAG Pharmaceuticals' Newly Approved Feraheme According to Latest BioTrends Report

...ct that Nephrologists continue to reserve it for patients with extremely elevated PTH, seems to hold it back from being used in more than one-third of hemodialysis patients. In the oral Vitamin D market, Q209 marked the first quarter where Abbott's Zemplar capsules saw a year over year decrease in market share. ...

Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)

...a generic version of Ferrlecit (sodium ferric gluconate complex in sucrose injection), a drug indicated for the treatment of iron deficiency anemia in hemodialysis patients receiving supplemental epoetin therapy. GeneraMedix has an Abbreviated New Drug Application (ANDA) on file with the FDA for a sodium ...

For Some Kidney Patients, Home Dialysis Is Better

...heir quality of life. Studies suggest that home hemodialysis administered overnight, otherwise known as "noctur...meritus of Northwest Kidney Centers in Seattle. hemodialysis is one of two main types of dialysis treatment adm...s own abdomen as a filtering device.) When home hemodialysis is performed overnight, the patient sleeps while t...

Hemodialysis in Medical Technology

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

... -- Title: Analysis of Potassium Profiles Among hemodialysis (HD) Patients Authors: John Rob...ion in Tests of Anemia and Iron Status in hemodialysis Patients Authors: David B. Van Wyck(1), ... Teaching Tools for Phosphorus Control in hemodialysis Unit Authors: Carol Allen DaVit...

DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference

... includes developments in pediatric dialysis, home hemodialysis and CKD education. In particular, DaVita's Abstrac...c Parenteral Nutrition at a Pediatric hemodialysis Unit Kathleen Traficanti, BS, RD ...NN -- Profiles of Successful Daily Home hemodialysis Patient-Care Partner Dyads: From Mutu...

For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold

...rventional radiology can be found online at www.SIRweb.org . Abstract 121: "Evaluation of Post-Interventional Patency of AV Fistulas in Elderly hemodialysis Patients," M.P. Bazylewicz, Dartmouth Medical School, Hanover, N.H.; A. Forauer, Dartmouth-Hitchcock Medical Center -- vascular and interventional rad...

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

... failure experienced greater risks for death and serious cardiovascular events (including myocardial infarction, stroke, congestive heart failure, and hemodialysis vascular access thrombosis) when administered ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in two clinica...

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting

...xperienced greater risks for death and serious cardiovascular events (including myocardial infarction, stroke, congestive heart failure, and hemodialysis vascular access thrombosis) when administered ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in t...

Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products

... addressing the critical financial and clinical needs of the care provider. The OLpur(TM) H2H is an add-on module that allows the most common types of hemodialysis machines to be used for on-line HDF therapy. The OLpur(TM) MD220 filter employs our proprietary Mid-Dilution diafiltration technology and is sold and ...

Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics

... is available at http://www.anesiva.com/img/ZingoPackage.pdf . In addition to the hospital population, opportunities exist for Zingo in children in hemodialysis centers, as well as physicians' offices and clinical laboratories. In March, Anesiva submitted a supplemental New Drug Application with the U.S. Food ...

Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference

...ly in patients with diabetes and/or hypertension. Nephropathy (kidney disease) is a common problem in diabetic patients, often leading to the need for hemodialysis or kidney transplant. After 12 weeks of treatment with XL784 the baseline normalized ACR (end of treatment/baseline ACR) in the XL784 group was 9.9% ...

NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal Week 2007

... Number of active users of NxStage Home hemodialysis System exceeds 2007 patients in 2007, having in...ted for home use and the first truly portable home hemodialysis machine, announced that this month it has reached ... 1957 as of September 30, 2007. More frequent home hemodialysis with the NxStage System One has been shown to offe...

Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks

...gs demonstrate that MIRCERA was administered up to once every four weeks in hemodialysis patients without sacrificing hemoglobin stability," said Nathan Levin, M.D....in The Lancet that these results should be generalizable to the maintenance hemodialysis population and that we believe this drug should be an option to epoetin for...

Hemodialysis in Medical Products

XTD Hemodialysis Access Graft Thrombectomy Catheter

Description: The XTD Thrombectomy catheter is a mechanical catheter intended to percutaneously break-up and remove thrombus from occluded hemodialysis access grafts. The disposable catheter requires no external console and consists of a rotatable, spiral shaft which extends beyond the 6F plastic sheath as a fle...
Company:Xtrak Medical, Inc.

ThromCat™ System

Description:...ith its quick set-up, excellent deliverability, and one-button control. The ThromCat™ System quickly and reliably removes thrombus from synthetic hemodialysis access grafts and native vessel dialysis fistulae 2.5 mm to 7.0 mm in diameter....
Company:Kensey Nash Corporation

Thrombex PMT System

Description:...T system is a self-contained, disposable clot-removal device that uses a motor-driven catheter and vacuum source to break up and remove thrombi from a hemodialysis graft....
Company:Edwards Lifesciences Corporation

Clo-Sur P.A.D. Nonwoven Hydrophilic Wound Dressing

Features:...g from the placement or removal of percutaneous catheter or tubes. Clo-Sur P.A.D. promotes the control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. Clo-Sur P.A.D. is patient-friendly and is simple to remove by patients. ...
Company:Medtronic Vascular

Hemodialysis in Medical Definition

Medical procedure

... Magnetoencephalography Therapeutic See also: Therapy , List of surgical procedures Precordial thump Politzerization hemodialysis Hemofiltration Plasmapheresis Apheresis Extracorporeal membrane oxygenation (ECMO) Cancer immunotherapy Cancer vaccine Cer...

Hemodialysis in Medical Dictionary

Toxins

...ard Toxins A&B (Meridian Bioscience, Cincinnati, OH) (ImmunoCard) ... of Clostridium difficile toxin : comparison of enzyme ... High-flux hemodialysis (which removes large toxins ) reduces the risk of premature death in many patients with chronic kidney disease (CKD), according to a study .....

Hemolysis

...of red blood cells ... If intravascular hemolysis continues, the hemoglobin dimers are in excess in ... Detection of hemolysis risk during hemodialysis using the transonic HDO1 Flow-QC Monitor ... The incidence of hemolysis related to flow restriction could be ... Hemolysis . Hemolysis . Mac...

Dialysis

...rom the access point in the body to a dialysis machine. ... Dialysis is most often used for patients who have kidney failure, but it can ... hemodialysis OVERVIEW Dialysis is a treatment for severe kidney ... for initiation of dialysis in chronic kidney disease ... and maintenance dialysi...

Carpal tunnel syndrome

... Usually, carpal tunnel syndrome (CTS) is considered an inflammatory disorder ... Carpal tunnel syndrome can also be caused by long-term hemodialysis and diseases ... ...

Aspirin overdose

... in your body. ... overdose is extremely severe, hemodialysis may be needed to remove aspirin from your blood....e overdose . ... overdose is extremely severe, hemodialysis may be needed to remove ... Q: How many hours ... in your body. ... overdose is extremely severe, hemodialysis may be needed to remove aspirin from your blood....

Hemodialysis in Biological News

Hopkins AIDS experts issue warning about global efforts to provide drug therapies

... The other two precedents are the introduction of hemodialysis for end-stage kidney disease in the 1960s and allo...ng follow up. Indeed, people who benefit most from hemodialysis are the ones who strictly follow their physician's...nitially, however, who would most likely adhere to hemodialysis therapy was determined by using "social-worth" cri...

Hemodialysis in Biological Technology

Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company

WALTHAM, Mass., March 5 /PRNewswire/ -- Proteon Therapeutics, Inc., announced today that it has successfully completed a $38 million Series B equity financing, led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund L.P. This announcement follows the initiation of a Phase 1/2 human clin...

NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population

LAWRENCE, Mass., July 23 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced ongoing public access to current summary information derived from a registry of NxStage patients with end-stage renal-disease (ESRD...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... failure experienced greater risks for death and serious cardiovascular events (including myocardial infarction, stroke, congestive heart failure, and hemodialysis vascular access thrombosis) when administered ESAs to target higher versus lower hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 g/dL) in two clinica...

Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55

... results for AMG 223 from its recently completed Phase 1 study in normal healthy patients and Phase 2 study in subjects with chronic kidney disease on hemodialysis with hyperphosphatemia. AMG 223 appeared to be well tolerated and showed a statistically significant reduction in serum phosphorus compared with plac...

BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

...the Vitamin D market, with over 50% of Nephrologists reporting they would shift away from IV Vitamin D to oral Vitamin D as their first line choice in hemodialysis patients. Another change in this market may be in the use of Nutritional Vitamin D, with over one third of Nephrologists expecting to increase their ...

Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors

.... Stoll was Executive Vice-President of Fresenius Medical Care - North America, a leading manufacturer and distributor of dialysis products, including hemodialysis machines and filters, and operator of more than 1,500 outpatient dialysis clinics in the United States. From 1991 to 1998, he was President a...

European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report

...hrologists project Aranesp will maintain its market leader position in both dialysis and CKD. In general, IV iron is reserved for patients on hemodialysis with about 65% of those treated receiving a consistent maintenance dose. The use of oral iron is more commonplace than the use of IV iron among CKD p...

BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

...r three quarters of RDs have used Renvela in their hemodialysis patients, however, Renagel and FMC's PhosLo remain...plar IV is the overwhelming market share leader in hemodialysis and leads in every type of dialysis unit, Hectorol...of Sensipar. Treatment prevalence with Sensipar in hemodialysis patients, according to both MDs and RDs has been l...

NxStage Announces Streamline(TM) Blood Tubing Set Supply Agreement with Renal Advantage Inc.

...has been a strong strategic partner in expanding availability of daily home hemodialysis therapy with NxStage's System One, and a long-term customer of our Medisyst...elationship and be part of NxStage's continued pioneering work in both home hemodialysis and the in-center market." NxStage's latest generation blood tubing set i...

New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices

...nce therapy (by extending dosing frequency, for example) instead of discontinuing therapy. American Regent's Venofer is the market share leader in the hemodialysis market over Watson's Ferrlecit. In the CKD market, similar to the dialysis market, Anemia Managers are often in charge of monitoring lab values and ...

Hemodialysis in Biological Definition

Dialysis

...ypes of dialysis 3 Peritoneal dialysis 4 hemodialysis The decision to dialyse In acute rena...Types of dialysis The two types of dialysis are hemodialysis and peritoneal dialysis . In hemodialysis , the patient's blood is passed through a tube int...